Treatment with the Antipsychotic Agent, Risperidone, Reduces Disease Severity in Experimental Autoimmune Encephalomyelitis

Lurasidone in the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo- and Olanzapine-Controlled Study

(2011) Herbert Y. Meltzer et al.   AMERICAN JOURNAL OF PSYCHIATRY

Dopamine Induces IL-6-Dependent IL-17 Production via D1-Like Receptor on CD4 Naive T Cells and D1-Like Receptor Antagonist SCH-23390 Inhibits Cartilage Destruction in a Human Rheumatoid Arthritis/SCID Mouse Chimera Model

(2011) K. Nakano et al.   JOURNAL OF IMMUNOLOGY

Interferon-γ Orchestrates the Number and Function of Th17 Cells in Experimental Autoimmune Encephalomyelitis

(2011) Nele Berghmans et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Inflammatory processes in schizophrenia: A promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond

(2011) Urs Meyer et al.   PHARMACOLOGY & THERAPEUTICS

Glatiramer Acetate Treatment Directly Targets CD11b+ Ly6G− Monocytes and Enhances the Suppression of Autoreactive T cells in Experimental Autoimmune Encephalomyelitis

(2011) A. Toker et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis

(2010) Áine C. Murphy et al.   BRAIN BEHAVIOR AND IMMUNITY

Dopaminergic mechanisms of reinstatement of MDMA-seeking behaviour in rats

(2010) S Schenk et al.   BRITISH JOURNAL OF PHARMACOLOGY

Dopamine released by dendritic cells polarizes Th2 differentiation

(2009) K. Nakano et al.   INTERNATIONAL IMMUNOLOGY

Role of dopamine in the physiology of T-cells and dendritic cells

(2009) Rodrigo Pacheco et al.   JOURNAL OF NEUROIMMUNOLOGY

Magnetic resonance evidence of cerebellar cortical pathology in multiple sclerosis

(2009) M. Calabrese et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Schizophrenia

(2009) Jim van Os et al.   LANCET

Antagonizing dopamine D1-like receptor inhibits Th17 cell differentiation: Preventive and therapeutic effects on experimental autoimmune encephalomyelitis

(2008) Kazuhisa Nakano et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Multiple sclerosis: new treatment trials and emerging therapeutic targets

(2008) Tracy DeAngelis et al.   CURRENT OPINION IN NEUROLOGY

Type II-activated macrophages suppress the development of experimental autoimmune encephalomyelitis

(2008) Joanna B Tierney et al.   IMMUNOLOGY AND CELL BIOLOGY

The antipsychotic spiperone attenuates inflammatory response in cultured microglia via the reduction of proinflammatory cytokine expression and nitric oxide production

(2008) Long Tai Zheng et al.   JOURNAL OF NEUROCHEMISTRY

Inhibitory effects of aripiprazole on interferon--induced microglial activation via intracellular Ca2+regulationin vitro

(2008) Takahiro Kato et al.   JOURNAL OF NEUROCHEMISTRY

Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice

(2008) Haruhiko Sugino et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Inflammatory Cytokine Alterations in Schizophrenia: A Systematic Quantitative Review

(2007) Stéphane Potvin et al.   BIOLOGICAL PSYCHIATRY

The effect of atypical antipsychotics, perospirone, ziprasidone and quetiapine on microglial activation induced by interferon-γ

(2007) Qian Bian et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY